Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LeanRx is a digital health company that operates a telehealth platform specializing in medical weight loss and metabolic health management. The company facilitates patient access to GLP-1 receptor agonists, including semaglutide and tirzepatide, by connecting them with licensed medical providers for virtual consultations. LeanRx focuses on providing a streamlined, cost-effective path for individuals to receive clinical evaluations and prescriptions for chronic weight management. Their service model includes medication fulfillment, often utilizing compounded formulations to address supply shortages and high costs associated with brand-name drugs. By combining clinical oversight with convenient digital access, LeanRx aims to support long-term weight loss goals through evidence-based pharmacological interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lean Rx.